NHS issues alert to anyone taking co-codamol | UK | News
NHS has issued a warning about the long-term use of co-donation, which is a widely used painkillery, which is widely used by millions of people throughout England. Each year, tens of millions of prescriptions are given for auxiliary ko-dodamol, and pharmacists distribute 650,000 additional prescriptions on those authorized by GPS.
While doctors and pharmacists normally provide guidance on how long the drug should last, the NHS emphasized the risks for people who buy low-strength co-dodging on the counter. The form of this drug can be obtained from non -prescription pharmacies, which makes it easier for people to take without professional control.
The NHS guidance states that the co-dodel purchased from a pharmacy should not last for more than three days. If the pain continues beyond this time, it is recommended that people talk to a pharmacist or GP.
Long -term use can lead to tolerance, ie higher doses to achieve the effect that eliminates the same pain. Some individuals can even develop hyperaljects, a condition in which the body becomes more sensitive to pain.
In addition to tolerance, there is a risk of addiction due to the codeine component of co-technamol. Codein is an opioid and repeated or long -term use can make the body dependent on it.
To reduce risks, doctors can regularly review the doses to ensure that patients take only what is necessary to manage their pain.
Ko-Koodamol is subject to different arrangements worldwide. In some countries, the drug is completely restricted or prohibited due to the codeine content.
For example, in the United States, it is classified as a codeine-controlled substance and is not available on the co-dhinol counter. Similar restrictions are found in Australia, Canada, New Zealand and some European countries.
The NHS warning reminds that even commonly used drugs can carry risks if not taken correctly.
People who rely on the auxiliary assistant co-co-co -ochanger are encouraged to follow the three-day limit and receive professional advice if the pain does not heal.
This guidance is part of a wider effort to ensure the safe use of painkillers and to prevent potential complications from opioid drugs.
